A PHASE II TRIAL OF BEVACIZUMAB COMBINED WITH CHEMOTHERAPY IN PATIENTS WITH METASTATIC WELL-DIFFERENTIATED DUODENO-PANCREATIC ENDOCRINE TUMORS (BETTER STUDY)

被引：0
|
作者：
Seitz, J. [1 ]
Smith, D. [2 ]
O'Toole, D. [3 ]
Lepere, C. [4 ]
Dromain, C. [5 ]
Gorana, A. [6 ]
Mitry, E. [7 ]
Ducreux, M. P. [8 ]
机构：
[1] Hop Enfants La Timone, Marseille, France
[2] Hop St Andre, Bordeaux, France
[3] Hop Beaujon, Clichy, France
[4] Hop Europeen Georges Pompidou, Paris, France
[5] Inst Gustave Roussy, Villejuif, France
[6] Labs Roche, Boulogne, France
[7] Inst Curie, Paris, France
[8] Inst Cancerol Gustave Roussy, Villejuif, France
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：378 / 378
页数：1
相关论文
共 50 条
  • [21] METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours
    Glasberg, Joao
    Talans, Aley
    Giollo, Thomas Rivelli
    Recchimuzzi, Debora Zachello
    Bezerra Neto, Joao Evangelista
    Mendonza Lopez, Rossana Veronica
    Gehm Hoff, Paulo Marcelo
    Riechelmann, Rachel P.
    ECANCERMEDICALSCIENCE, 2022, 16
  • [22] PHASE II STUDY OF SUNITINIB (SU) IN JAPANESE PATIENTS WITH WELL-DIFFERENTIATED PANCREATIC NEUROENDOCRINE TUMOR (NET)
    Igarashi, H.
    Okusaka, T.
    Ito, T.
    Nishida, T.
    Hashigaki, S.
    Kimura, N.
    Ohki, E.
    Sawaki, A.
    Yamao, K.
    Imamura, M.
    ANNALS OF ONCOLOGY, 2013, 24
  • [23] Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial
    Krug, Sebastian
    Kegel, Thomas
    Gress, Thomas M.
    Rinke, Anja
    Apostolidis, Leonidas
    Jann, Henning
    Koenig, Alexander
    Hoersch, Dieter
    Schrader, Joerg
    Ettrich, Thomas J.
    Richter, Michael
    Steighardt, Joerg
    Michl, Patrick
    BMC CANCER, 2021, 21 (01)
  • [24] A multicenter single-arm pilot study of ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors: the RamuNET trial
    Krug, S.
    Michl, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 49 - 49
  • [25] Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial
    Sebastian Krug
    Thomas Kegel
    Thomas M. Gress
    Anja Rinke
    Leonidas Apostolidis
    Henning Jann
    Alexander König
    Dieter Hörsch
    Jörg Schrader
    Thomas J. Ettrich
    Michael Richter
    Jörg Steighardt
    Patrick Michl
    BMC Cancer, 21
  • [26] Phase II trial of bevacizumab, gemcitabine, oxaliplatin in patients with metastatic pancreatic adenocarcinoma
    Kim, G. P.
    Oberg, A. L.
    Foster, N. R.
    Jaslowski, A.
    Flynn, P. J.
    Campbell, D.
    Hedrick, E.
    Gray, L.
    Grothey, A.
    Alberts, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [27] Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor (vol 31, pg 1265, 2013)
    Ito, Tetsuhide
    Okusaka, Takuji
    Nishida, Toshirou
    Yamao, Kenji
    Igarashi, Hisato
    Morizane, Chigusa
    Kondo, Shunsuke
    Mizuno, Nobumasa
    Hara, Kazuo
    Sawaki, Akira
    Hashigaki, Satoshi
    Kimura, Nobuyuki
    Murakami, Mami
    Ohki, Emiko
    Chao, Richard C.
    Imamura, Masayuki
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (03) : 591 - 591
  • [28] PHASE II TRIAL OF COMBINED CHEMOTHERAPY WITH IRINOTECAN, S-1, AND BEVACIZUMAB IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Komatsu, Y.
    Yuki, S.
    Sogabe, S.
    Nakamura, M.
    Hatanaka, K.
    Miyagishima, T.
    Kudo, M.
    Munakata, M.
    Sakata, Y.
    Asaka, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 197 - 197
  • [29] Phase II trial of combined chemotherapy with irinotecan, S-1, and bevacizumab in patients with metastatic colorectal cancer
    Hatanaka, K.
    Komatsu, Y.
    Yuki, S.
    Nakamura, M.
    Miyagishima, T.
    Kudo, M.
    Munakata, M.
    Sakata, Y.
    Asaka, M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 336 - 336
  • [30] Bevacizumab combined with chemotherapy in the treatment of advanced/metastatic gastro-entero-pancreatic tumours: interim safety results from the phase II BETTER study
    Mitry, E.
    Ducreux, M.
    Dominguez, S.
    Louvet, C.
    Seitz, J. F.
    Smith, D.
    Kurtz, J. E.
    Lombard-Bohas, C.
    Ruszniewski, P.
    O'Toole, D.
    EJC SUPPLEMENTS, 2009, 7 (02): : 383 - 383
12345